Polypectomy in Patients Taking Dual Antiplatelet Agents
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Current guidelines recommend discontinuation of antiplatelets (i.e clopidogrel) for 7 days in
patients taking DAT (dual antiplatelet therapy) before colonoscopy and polypectomy. The
purpose of this study was to examine if a) discontinuation of these drugs reduces bleeding
risks during polypectomy and if b) discontinuation of these drugs increases the occurence of
thromboembolic events.